Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase S01.233: plasmin

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Inhibitors Pharma

(Topics flags: S Structure, A Assay, T Target, K Knockout, P Specificity, E Expression, V Review, M Mutation, I Inhibitor, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Pirillo,E., Freenor,V., Wamba,B.E.N., Bhatnagar,S., Mondal,T. and Tushir-Singh,J.
    An evolutionary T119R substitution in the macaque T-cell immunoreceptor TIGIT enables proteolytic shedding and reveals clinical antibody vulnerabilities
    J Biol Chem (2025) , 110962-110962. PubMed  Europe PubMed DOI
    2. 2024
  2. Al-Horani,R.A. and Aliter,K.F.
    Triple Action of Lignosulfonic Acid Sodium: Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic
    Med Chem (2024) 20, 414-421. PubMed  Europe PubMed DOI  I
  3. Al-Horani,R.A.
    Revisiting the effect of cholesteryl sulfate on clotting and fibrinolysis: Inhibition of human thrombin and other human blood proteases
    Heliyon (2024) 10, e28017-e28017. PubMed  Europe PubMed DOI  PMC  EPMC  I
  4. Barrett,C.D., Moore,P.K., Moore,E.E., Moore,H.B., Chandler,J.G., Siddiqui,H., Maginot,E.R., Sauaia,A., Perez-Calatayud,A.A., Buesing,K., Wang,J., Davila-Chapa,C., Hershberger,D., Douglas,I., Pieracci,F.M. and Yaffe,M.B.
    Plasminogen Degradation by Neutrophil Elastase in Pleural Infection, Not High Plasminogen Activator Inhibitor-1 (PAI-1), is the Cause of Intrapleural Lytic Failure
    Chest (2024) PubMed  Europe PubMed DOI
  5. Bharadwaj,A.G., Okura,G.C., Woods,J.W., Allen,E.A., Miller,V.A., Kempster,E., Hancock,M.A., Gujar,S., Slibinskas,R. and Waisman,D.M.
    Identification and characterization of calreticulin as a novel plasminogen receptor
    J Biol Chem (2024) 300, 105465-105465. PubMed  Europe PubMed DOI  PMC  EPMC
  6. Brito-Robinson,T., Ayinuola,Y.A., Ploplis,V.A. and Castellino,F.J.
    Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease
    Front Cardiovasc Med (2024) 11, 1406953-1406953. PubMed  Europe PubMed DOI  PMC  EPMC
  7. Dai,X., Yang,J., Lv,L., Wang,C. and Bian,L.
    Molecular recognition and binding between human plasminogen Kringle 5 and alpha-chain of human complement component C3b by frontal chromatography and dynamics simulation
    J Chromatogr A (2024) 1718, 464673-464673. PubMed  Europe PubMed DOI
  8. Dickeson,S.K., Kumar,S., Sun,M.F., Litvak,M., He,T.Z., Phillips,D.R., Roberts,E.T., Feener,E.P., Law,R.H.P. and Gailani,D.
    A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogens
    Blood (2024) 143, 641-650. PubMed  Europe PubMed DOI  PMC  EPMC
  9. Otmani,H.E., Vanhoorelbeke,K. and Tersteeg,C.
    Improving our understanding on the clinical role of plasmin-mediated von Willebrand factor degradation
    Curr Opin Hematol (2024) 31, 245-250. PubMed  Europe PubMed DOI  V
  10. Tang,D., Khakzad,H., Hjortswang,E., Malmstrom,L., Ekstrom,S., Happonen,L. and Malmstrom,J.
    Streptolysin O accelerates the conversion of plasminogen to plasmin
    Nat Commun (2024) 15, 10212-10212. PubMed  Europe PubMed DOI  PMC  EPMC
  11. Uguen,K., Frey,T., Muthaffar,O., Decarie,J.C., Ameziane,N., Boissel,S., Baradaran-Heravi,Y., Rauch,A., Oprea,G., Rad,A., Steindl,K. and Michaud,J.L.
    Loss of tissue-type plasminogen activator causes multiple developmental anomalies
    Brain Commun (2024) 6, fcae408-fcae408. PubMed  Europe PubMed DOI  PMC  EPMC
  12. Vrzalova,A. and Vrzal,R.
    Orchestra of ligand-activated transcription factors in the molecular symphony of SERPINE 1 / PAI-1 gene regulation
    Biochimie (2024) PubMed  Europe PubMed DOI  V
    13. 2023
  13. Afosah,D.K., Fayyad,R.M., Puliafico,V.R., Merrell,S., Langmia,E.K., Diagne,S.R., Al-Horani,R.A. and Desai,U.R.
    Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G
    Biomolecules (2023) 13 PubMed  Europe PubMed DOI  PMC  EPMC  I
  14. Ferreira,G.C., Bomediano Camillo,L.M. and Sasaki,S.D.
    Structural and functional properties of rBmTI-A: A Kunitz-BPTI serine protease inhibitor with therapeutical potential
    Biochimie (2023) 204, 7- PubMed  Europe PubMed DOI
  15. Kaur,P., Sethi,D., Hade,M.D., Kaur,J. and Dikshit,K.L.
    C-terminal lysine residues enhance plasminogen activation by inducing conformational flexibility and stabilization of activator complex of staphylokinase with plasmin
    Arch Biochem Biophys (2023) 743, 109671-109671. PubMed  Europe PubMed DOI
  16. Moore-Lotridge,S.N., Hajdu,K.S., Hou,B.Q., Gibson,B.H.Y. and Schoenecker,J.G.
    Maintaining the balance: the critical role of plasmin activity in orthopedic surgery injury response
    J Thromb Haemost (2023) 21, 2653-2665. PubMed  Europe PubMed DOI  V
  17. Yang,J., Cha,L., Wang,Y., Zhang,Q., Tang,X., Shao,J. and Duan,Z.
    L-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis
    Nat Prod Bioprospect (2023) 13, 48-48. PubMed  Europe PubMed DOI  PMC  EPMC
    18. 2022
  18. Bryk-Wiazania,A.H., Cysewski,D., Oclon,E. and Undas,A.
    Mass-spectrometric identification of oxidative modifications in plasma-purified plasminogen: Association with hypofibrinolysis in patients with acute pulmonary embolism
    Biochem Biophys Res Commun (2022) 621, 53-58. PubMed  Europe PubMed DOI
  19. Loef,E.J., Sheppard,H.M., Birch,N.P. and Dunbar,P.R.
    Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses
    J Biol Chem (2022) 298, 102112-102112. PubMed  Europe PubMed DOI  PMC  EPMC
  20. Mehner,C., Hockla,A., Coban,M., Madden,B., Estrada,R., Radisky,D.C. and Radisky,E.S.
    Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma
    J Biol Chem (2022) 298, 102146-102146. PubMed  Europe PubMed DOI  PMC  EPMC
  21. Pascini,T.V., Jeong,Y.J., Huang,W., Pala,Z.R., Sa,J.M., Wells,M.B., Kizito,C., Sweeney,B., Alves E Silva, Andrew,D.J., Jacobs-Lorena,M. and Vega-Rodriguez,J.
    Transgenic Anopheles mosquitoes expressing human PAI-1 impair malaria transmission
    Nat Commun (2022) 13, 2949-2949. PubMed  Europe PubMed DOI  PMC  EPMC
  22. Vasilyeva,A., Yurina,L., Ivanov,V., Azarova,D., Gavrilina,E., Indeykina,M., Bugrova,A., Kononikhin,A., Nikolaev,E. and Rosenfeld,M.
    The effect of hypochlorite- and peroxide-induced oxidation of plasminogen on damage to the structure and biological activity
    Int J Biol Macromol (2022) 206, 64-73. PubMed  Europe PubMed DOI
    23. 2021
  23. Choudhary,K., Patel,P.K., Are,V.N., Makde,R.D. and Hajela,K.
    Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate
    Blood Coagul Fibrinolysis (2021) 32, 504-512. PubMed  Europe PubMed DOI
  24. Friedrich,C., Neugebauer,L., Zamora,M., Robles,J.P., Martinez de la Escalera,G., Clapp,C., Bertsch,T. and Triebel,J.
    Plasmin generates vasoinhibin-like peptides by cleaving prolactin and placental lactogen
    Mol Cell Endocrinol (2021) 538, 111471-111471. PubMed  Europe PubMed DOI
  25. Heestermans,M., Naudin,C., Mailer,R.K., Konrath,S., Klaetschke,K., Jamsa,A., Frye,M., Deppermann,C., Pula,G., Kuta,P., Friese,M.A., Gelderblom,M., Sickmann,A., Preston,R.J.S., Nofer,J.R., Rose-John,S., Butler,L.M., Salomon,O., Stavrou,E.X. and Renne,T.
    Identification of the factor XII contact activation site enables sensitive coagulation diagnostics
    Nat Commun (2021) 12, 5596-5596. PubMed  Europe PubMed DOI  PMC  EPMC
  26. Ismail,A.A., Shaker,B.T. and Bajou,K.
    The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis
    Int J Mol Sci (2021) 23 PubMed  Europe PubMed DOI  PMC  EPMC
  27. Kryza,T., Khan,T., Lovell,S., Harrington,B.S., Yin,J., Porazinski,S., Pajic,M., Koistinen,H., Rantala,J.K., Dreyer,T., Magdolen,V., Reuning,U., He,Y., Tate,E.W. and Hooper,J.D.
    Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1
    Nat Chem Biol (2021) PubMed  Europe PubMed DOI
  28. Kunnapuu,J., Bokharaie,H. and Jeltsch,M.
    Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
    Biology (Basel) (2021) 10 PubMed  Europe PubMed DOI  PMC  EPMC
  29. Miszta,A., Huskens,D., Donkervoort,D., Roberts,M.J.M., Wolberg,A.S. and de Laat,B.
    Assessing Plasmin Generation in Health and Disease
    Int J Mol Sci (2021) 22 PubMed  Europe PubMed DOI  PMC  EPMC  V
  30. Pala,Z.R., Ernest,M., Sweeney,B., Jeong,Y.J., Pascini,T.V., Alves E Silva and Vega-Rodriguez,J.
    Beyond cuts and scrapes: plasmin in malaria and other vector-borne diseases
    Trends Parasitol (2021) PubMed  Europe PubMed DOI  V
  31. Walvekar,V.A., Ramesh,K., Jobichen,C., Kannan,M., Sivaraman,J., Kini,R.M. and Mok,Y.K.
    Crystal structure of Aedes aegypti trypsin inhibitor in complex with mu-plasmin reveals role for scaffold stability in Kazal-type serine protease inhibitor
    Protein Sci (2021) PubMed  Europe PubMed DOI
  32. Wang,M., Xie,Y. and Qin,D.
    Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases
    Brain Res Bull (2021) 166, 172-184. PubMed  Europe PubMed DOI
  33. Yazgan,N.N., Bulat,T., Topcu,A., Dudak,F.C., Boyaci,I.H. and Tamer,U.
    Surface-enhanced Raman scattering-based detection of plasmin activity by specific peptide substrate
    Food Chem (2021) 372, 131235-131235. PubMed  Europe PubMed DOI
    34. 2020
  34. Ayinuola,Y.A., Brito-Robinson,T., Ayinuola,O., Beck,J.E., Cruz-Topete,D., Lee,S.W., Ploplis,V.A. and Castellino,F.J.
    Streptococcus co-opts a conformational lock in human plasminogen to facilitate streptokinase cleavage and bacterial virulence
    J Biol Chem (2020) PubMed  Europe PubMed DOI
  35. Baghban,R., Farajnia,S., Ghasemi,Y., Hoseinpoor,R., Safary,A., Mortazavi,M. and Zarghami,N.
    Mutational Analysis of Ocriplasmin to Reduce Proteolytic and Autolytic Activity in Pichia pastoris
    Biol Proced Online (2020) 22, 25-25. PubMed  Europe PubMed DOI  PMC  EPMC
  36. Brunet,J.G., Sharma,T., Tasneem,S., Liang,M., Wilson,M.D., Rivard,G.E. and Hayward,C.P.M.
    Thrombin generation abnormalities in Quebec platelet disorder
    Int J Lab Hematol (2020) , e13302-e13302. PubMed  Europe PubMed DOI  I
  37. Heissig,B., Salama,Y., Takahashi,S., Osada,T. and Hattori,K.
    The multifaceted role of plasminogen in inflammation
    Cell Signal (2020) 75, 109761-109761. PubMed  Europe PubMed DOI  PMC  EPMC  V
  38. Klaassen,K., Stankovic,B., Zukic,B., Kotur,N., Gasic,V., Pavlovic,S. and Stojiljkovic,M.
    Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection
    Infect Genet Evol (2020) 84, 104498-104498. PubMed  Europe PubMed DOI  PMC  EPMC
  39. Marceau,F., Rivard,G.E., Gauthier,J.M., Binkley,K.E., Bonnefoy,A., Boccon-Gibod,I., Bouillet,L., Picard,M., Levesque,G., Elfassy,H.L., Bachelard,H., Hebert,J. and Bork,K.
    Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
    Front Med (Lausanne) (2020) 7, 358-358. PubMed  Europe PubMed DOI  PMC  EPMC  I
  40. Medcalf,R.L., Keragala,C.B. and Myles,P.S.
    Fibrinolysis and COVID-19: A plasmin paradox
    J Thromb Haemost (2020) PubMed  Europe PubMed DOI  PMC  EPMC
  41. Miles,L.A., Vago,J.P., Sousa,L.P. and Parmer,R.J.
    Functions of the Plasminogen Receptor, Plg-RKT
    J Thromb Haemost (2020) PubMed  Europe PubMed DOI  V
  42. Moraes,C.T.P., Longo,J., Silva,L.B., Pimenta,D.C., Carvalho,E., Morone,M.S.L.C., da Ros,N., Serrano,S.M.T., Santos,A.C.M., Piazza,R.M.F., Barbosa,A.S. and Elias,W.P.
    Surface Protein Dispersin of Enteroaggregative Escherichia coli Binds Plasminogen That Is Converted Into Active Plasmin
    Front Microbiol (2020) 11, 1222-1222. PubMed  Europe PubMed DOI  PMC  EPMC
  43. Pedersen,N.B., Stolberg,C.R., Mundbjerg,L.H., Juhl,C.B., Gram,B., Funch-Jensen,P., de Maat,M.P.M., Munster,A.B. and Bladbjerg,E.M.
    Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery
    Clin Obes (2020) , e12397-e12397. PubMed  Europe PubMed DOI
  44. Sanda,T., Yoshimura,M., Hyodo,K., Ishii,H. and Yamashita,T.
    Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on Spontaneous Thrombolytic Activity during the Progression of Atherosclerosis in ApoE(-/-)-LDLR(-/-) Double-Knockout Mice
    Korean Circ J (2020) 50, 804-816. PubMed  Europe PubMed DOI  I
  45. Seth,S., Batra,J. and Srinivasan,S.
    COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
    Front Mol Biosci (2020) 7, 215-215. PubMed  Europe PubMed DOI  PMC  EPMC  V
  46. Steinmetzer,T., Pilgram,O., Wenzel,B.M. and Wiedemeyer,S.J.A.
    Fibrinolysis inhibitors: potential drugs for the treatment and prevention of bleeding
    J Med Chem (2020) 63, 1445-1472. PubMed  Europe PubMed DOI  I
  47. Suzuki,Y., Sano,H., Mochizuki,L., Honkura,N. and Urano,T.
    Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system
    Blood Adv (2020) 4, 5501-5511. PubMed  Europe PubMed DOI  PMC  EPMC
  48. Thierry,A.R.
    Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19
    Physiol Rev (2020) 100, 1597-1598. PubMed  Europe PubMed DOI  PMC  EPMC
  49. Vadivel,K., Zaiss,A.K., Kumar,Y., Fabian,F.M., Ismail,A.E.A., Arbing,M.A., Buchholz,W.G., Velander,W.H. and Bajaj,S.P.
    Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1
    J Clin Med (2020) 9 PubMed  Europe PubMed DOI  PMC  EPMC
  50. Weihs,F., Peh,A. and Dacres,H.
    A red-shifted bioluminescence resonance energy transfer (BRET) biosensing system for rapid measurement of plasmin activity in human plasma
    Anal Chim Acta (2020) 1102, 99-108. PubMed  Europe PubMed DOI  A
    51. 2019
  51. Barbosa da Cruz,D., Helms,J., Aquino,L.R., Stiel,L., Cougourdan,L., Broussard,C., Chafey,P., Ries-Kautt,M., Meziani,F., Toti,F., Gaussem,P. and Angles-Cano,E.
    DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma
    FASEB J (2019) 33, 14270-14280. PubMed  Europe PubMed DOI
  52. Swedberg,J.E., Wu,G., Mahatmanto,T., Durek,T., Caradoc-Davies,T.T., Whisstock,J.C., Law,R.H.P. and Craik,D.J.
    Highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma
    J Med Chem (2019) 62, 552-560. PubMed  Europe PubMed DOI
  53. Trinh,T.H.T., Kim,J., Lee,C.H. and Ryou,C.
    Non-ionic detergents Nonidet P-40 and Triton X-100 increase enzymatic activity of plasmin
    Biochem Biophys Res Commun (2019) 512, 314-318. PubMed  Europe PubMed DOI
  54. Wu,G., Quek,A.J., Caradoc-Davies,T.T., Ekkel,S.M., Mazzitelli,B., Whisstock,J.C. and Law,R.H.P.
    Structural studies of plasmin inhibition
    Biochem Soc Trans (2019) 47, 541-557. PubMed  Europe PubMed DOI  I
  55. Zhao,T., Houng,A. and Reed,G.L.
    Termination of bleeding by a specific anticatalytic antibody against plasmin
    J Thromb Haemost (2019) 17, 1461-1469. PubMed  Europe PubMed DOI
    56. 2018
  56. Clark,C.C., Mebius,M.M., de Maat,S., Tielens,A.G.M., DE Groot,P.G., Urbanus,R.T., Fijnheer,R., Hazenberg,B.P.C., van Hellemond,J.J. and Maas,C.
    Truncation of ADAMTS13 by plasmin enhances its activity in plasma
    Thromb Haemost (2018) 118, 471-479. PubMed  Europe PubMed DOI
  57. Nguyen,N.T.T., Rottgerding,F., Devraj,G., Lin,Y.P., Koenigs,A. and Kraiczy,P.
    The complement binding and inhibitory protein CbiA of Borrelia miyamotoi degrades extracellular matrix components by interacting with plasmin(ogen)
    Front Cell Infect Microbiol (2018) 8, 23-23. PubMed  Europe PubMed DOI  PMC  EPMC
    58. 2017
  58. Draxler,D.F., Sashindranath,M. and Medcalf,R.L.
    Plasmin: a modulator of immune function
    Semin Thromb Hemost (2017) 43, 143-153. PubMed  Europe PubMed DOI
  59. Law,R.H.P., Wu,G., Leung,E.W.W., Hidaka,K., Quek,A.J., Caradoc-Davies,T.T., Jeevarajah,D., Conroy,P.J., Kirby,N.M., Norton,R.S., Tsuda,Y. and Whisstock,J.C.
    X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors
    Blood Adv (2017) 1, 766-771. PubMed  Europe PubMed DOI  PMC  EPMC  S  I
  60. Schmidt,T.C., Eriksson,P.O., Gustafsson,D., Cosgrove,D., Frolund,B. and Bostrom,J.
    Discovery and evaluation of anti-fibrinolytic plasmin inhibitors derived from 5-(4-piperidyl)isoxazol-3-ol (4-PIOL)
    J Chem Inf Model (2017) 57, 1703-1714. PubMed  Europe PubMed DOI  I
  61. Shimazu,H., Munakata,S., Tashiro,Y., Salama,Y., Dhahri,D., Eiamboonsert,S., Ota,Y., Onoda,H., Tsuda,Y., Okada,Y., Nakauchi,H., Heissig,B. and Hattori,K.
    Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome
    Blood (2017) 130, 59-72. PubMed  Europe PubMed DOI  T
  62. Yang,C., Wang,L., Zhang,H., Yi,Q., Wang,L., Wang,H. and Song,L.
    The first CUB-domain containing serine protease from Chlamys farreri which might be involved in larval development and immune response
    Dev Comp Immunol (2017) 76, 163-168. PubMed  Europe PubMed DOI
  63. Yuan,Y., Zajicek,J., Qiu,C., Chandrahas,V., Lee,S.W., Ploplis,V.A. and Castellino,F.J.
    Conformationally organized lysine isosteres in Streptococcus pyogenes M protein mediate direct high-affinity binding to human plasminogen
    J Biol Chem (2017) 292, 15016-15027. PubMed  Europe PubMed DOI
  64. Yue,S.-L., Zhou,Z.-J., Peng,Y., Lin,L.-Z., Li,T.-J., Xing,Y.-T., Wang,F.-F., Li,C.-S. and Hu,Y.
    Development and verification of dynamic chromogenic method for determination of human plasmin activity
    Chin J Biol (2017) 30, 74-78.  A
    65. 2016
  65. Chen,Y.W., Yin,S., Lai,Y.J., Johnson,M.D. and Lin,C.Y.
    Plasminogen-dependent matriptase activation accelerates plasmin generation by differentiating primary human keratinocytes
    J Invest Dermatol (2016) 136, 1210-1218. PubMed  Europe PubMed DOI
  66. Gonzalez-Miguel,J., Siles-Lucas,M., Kartashev,V., Morchon,R. and Simon,F.
    Plasmin in parasitic chronic infections: friend or foe?
    Trends Parasitol (2016) 32, 325-335. PubMed  Europe PubMed DOI
  67. Hidaka,K., Gohda,K., Teno,N., Wanaka,K. and Tsuda,Y.
    Active site-directed plasmin inhibitors: extension on the P2 residue
    Bioorg Med Chem (2016) 24, 545-553. PubMed  Europe PubMed DOI  I
  68. Hinkes,S., Wuttke,A., Saupe,S.M., Ivanova,T., Wagner,S., Knorlein,A., Heine,A., Klebe,G. and Steinmetzer,T.
    Optimization of cyclic plasmin inhibitors: from benzamidines to benzylamines
    J Med Chem (2016) 59, 6370-6386. PubMed  Europe PubMed DOI  I
  69. Kakizoe,Y., Miyasato,Y., Onoue,T., Nakagawa,T., Hayata,M., Uchimura,K., Morinaga,J., Mizumoto,T., Adachi,M., Miyoshi,T., Sakai,Y., Tomita,K., Mukoyama,M. and Kitamura,K.
    A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity
    J Pharmacol Sci (2016) 132, 145-153. PubMed  Europe PubMed DOI  I
  70. Khan,M.A. and Haller,J.A.
    Ocriplasmin for treatment of vitreomacular traction: an update
    Ophthalmol Ther (2016) 5, 147-159. PubMed  Europe PubMed DOI  U
  71. Lee,Y.S., Wang,N.K., Chen,Y.P., Chen,K.J., Hwang,Y.S., Lai,C.C. and Wu,W.C.
    Plasmin enzyme-assisted vitrectomy in pediatric patients with vitreoretinal diseases
    Ophthalmic Res (2016) 56, 193-201. PubMed  Europe PubMed DOI  U
  72. Leung,L.L. and Morser,J.
    Plasmin as a complement C5 convertase
    EBioMedicine (2016) 5, 20-21. PubMed  Europe PubMed DOI  PMC  EPMC
  73. Maleki,A., Tohidi-Zand,S.R., Amirizadeh,N., Dehghan-Haghighi,J., Zanjani,H., Arish,M., Salari,A.M., Mirhosseini,S.M. and Abrishami,M.
    Intravitreal autologous plasmin prepared by urokinase for vitreolysis: a pilot study
    Eur J Ophthalmol (2016) 26, 67-70. PubMed  Europe PubMed DOI
  74. Morescalchi,F., Gambicorti,E., Duse,S., Costagliola,C. and Semeraro,F.
    From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety
    Expert Opin Drug Saf (2016) 15, 1267-1278. PubMed  Europe PubMed DOI  U
  75. Poturnayova,A., Karpisova,I., Castillo,G., Mezo,G., Kocsis,L., Csampai,A., Keresztes,Z. and Hianik,T.
    Detection of plasmin based on specific peptide substrate using acoustic transducer
    Sens Actuators, B Chem (2016) 223, 591-598. DOI  A
    76. 2015
  76. Al-Horani,R.A., Karuturi,R., White,D.T. and Desai,U.R.
    Plasmin regulation through allosteric, sulfated, small molecules
    Molecules (2015) 20, 608-624. PubMed  Europe PubMed DOI
  77. Alves,N.J. and Kline,J.A.
    Comparative study on the inhibition of plasmin and delta-plasmin via benzamidine derivatives
    Biochem Biophys Res Commun (2015) 457, 358-362. PubMed  Europe PubMed DOI  I
  78. Castillo,G., Pribransky,K., Mezo,G., Kocsis,L., Csampai,A., Nemeth,K., Keresztes,Z. and Hianik,T.
    Electrochemical and photometric detection of plasmin by specific peptide substrate
    Electroanalysis (2015) 27, 789-798. DOI  A
  79. Foley,J.H., Peterson,E.A., Lei,V., Wan,L.W., Krisinger,M.J. and Conway,E.M.
    Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses
    J Thromb Haemost (2015) 13, 610-618. PubMed  Europe PubMed DOI
  80. Gonzalez,T., Gaultney,R.A., Floden,A.M. and Brissette,C.A.
    Escherichia coli lipoprotein binds human plasminogen via an intramolecular domain
    Front Microbiol (2015) 6, 1095-1095. PubMed  Europe PubMed DOI  PMC  EPMC
  81. Khoshnevis,M. and Sebag,J.
    Pharmacologic vitreolysis with Ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders
    BioDrugs (2015) 29, 103-112. PubMed  Europe PubMed DOI  U
  82. Liu,R., Zhao,B., Zhang,Y., Gu,J., Yu,M., Song,H., Yu,M. and Mo,W.
    High-level expression, purification, and enzymatic characterization of truncated human plasminogen (Lys531-Asn791) in the methylotrophic yeast Pichia pastoris
    BMC Biotechnol (2015) 15, 50-50. PubMed  Europe PubMed DOI  PMC  EPMC  E
  83. Oudart,J.B., Brassart-Pasco,S., Vautrin,A., Sellier,C., Machado,C., Dupont-Deshorgue,A., Brassart,B., Baud,S., Dauchez,M., Monboisse,J.C., Harakat,D., Maquart,F.X. and Ramont,L.
    Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX
    Oncotarget (2015) 6, 3656-3668. PubMed  Europe PubMed DOI
  84. Singh,B., Al-Jubair,T., Voraganti,C., Andersson,T., Mukherjee,O., Su,Y.C., Zipfel,P. and Riesbeck,K.
    Moraxella catarrhalis binds plasminogen to evade host innate immunity
    Infect Immun (2015) 83, 3458-3469. PubMed  Europe PubMed DOI
    85. 2014
  85. Al-Horani,R.A. and Desai,U.R.
    Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders
    Med Res Rev (2014) 34, 1168-1216. PubMed  Europe PubMed DOI  V  I
  86. Bikker,F.J., Koop,G., Leusink,N.B., Nazmi,K., Kaman,W.E., Brand,H.S. and Veerman,E.C.
    Tailor made plasmin substrates as potential diagnostic tool to test for mastitis
    Vet Res Commun (2014) 38, 271-277. PubMed  Europe PubMed DOI  A  P
  87. Cheng,L., Pettersen,D., Ohlsson,B., Schell,P., Karle,M., Evertsson,E., Pahlen,S., Jonforsen,M., Plowright,A.T., Bostrom,J., Fex,T., Thelin,A., Hilgendorf,C., Xue,Y., Wahlund,G., Lindberg,W., Larsson,L.O. and Gustafsson,D.
    Discovery of the fibrinolysis inhibitor AZD6564, acting via interference of a protein-protein interaction
    ACS Med Chem Lett (2014) 5, 538-543. PubMed  Europe PubMed DOI  PMC  EPMC  S  I
  88. Gohda,K., Fujimori,K., Teno,N., Wanaka,K. and Tsuda,Y.
    Synthetic substrates specific to activated plasmin can monitor the enzymatic functional status in situ in breast cancer cells
    Chem Biol Drug Des (2014) 83, 52-57. PubMed  Europe PubMed DOI  A
  89. Hultman,K., Cortes-Canteli,M., Bounoutas,A., Richards,A.T., Strickland,S. and Norris,E.H.
    Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain
    J Thromb Haemost (2014) 12, 701-712. PubMed  Europe PubMed DOI  K
  90. Koyanagi,K., Narasaki,R., Yamamichi,S., Suzuki,E. and Hasumi,K.
    Mechanism of the action of SMTP-7, a novel small-molecule modulator of plasminogen activation
    Blood Coagul Fibrinolysis (2014) 25, 316-321. PubMed  Europe PubMed DOI
  91. Kumar,Y., Vadivel,K., Schmidt,A.E., Ogueli,G.I., Ponnuraj,S.M., Rannulu,N., Loo,J.A., Bajaj,M.S. and Bajaj,S.P.
    Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain
    Biochemistry (2014) 53, 505-517. PubMed  Europe PubMed DOI
  92. Sonderegger,P. and Matsumoto-Miyai,K.
    Activity-controlled proteolytic cleavage at the synapse
    Trends Neurosci (2014) 37, 413-423. PubMed  Europe PubMed DOI
  93. Teno,N., Gohda,K., Wanaka,K., Tsuda,Y., Sueda,T., Yamashita,Y. and Otsubo,T.
    Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin
    Bioorg Med Chem (2014) 22, 2339-2352. PubMed  Europe PubMed DOI  I
  94. Valapala,M., Maji,S., Borejdo,J. and Vishwanatha,J.K.
    Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis
    J Biol Chem (2014) 289, 15915-15926. PubMed  Europe PubMed DOI
  95. Verhamme,I.M. and Bock,P.E.
    Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism
    J Biol Chem (2014) 289, 28006-28018. PubMed  Europe PubMed DOI
    96. 2013
  96. Aguda,R., Caronna,A., Hunt,J., Koepf,E., Lindsay,M., Miller,C., Rebbeor,J., Silverstein,R., Stokes,K. and Zimmerman,T.
    Production and purification of TAL6003: a novel version of the protease plasmin
    Protein Expr Purif (2013) 88, 41-46. PubMed  Europe PubMed DOI  U
  97. Aneja,R., Datt,M., Yadav,S. and Sahni,G.
    Multiple exosites distributed across the three domains of streptokinase co-operate to generate high catalytic rates in the streptokinase-plasmin activator complex
    Biochemistry (2013) 52, 8957-8968. PubMed  Europe PubMed DOI
  98. Hoffmann,D.C., Willenborg,S., Koch,M., Zwolanek,D., Muller,S., Becker,A.K., Metzger,S., Ehrbar,M., Kurschat,P., Hellmich,M., Hubbell,J.A. and Eming,S.A.
    Proteolytic processing regulates placental growth factor activities
    J Biol Chem (2013) 288, 17976-17989. PubMed  Europe PubMed DOI  P
  99. Law,R.H., Abu-Ssaydeh,D. and Whisstock,J.C.
    New insights into the structure and function of the plasminogen/plasmin system
    Curr Opin Struct Biol (2013) 23, 836-841. PubMed  Europe PubMed DOI
  100. Millers,E.K., Johnson,L.A., Birrell,G.W., Masci,P.P., Lavin,M.F., de Jersey,J. and Guddat,L.W.
    The structure of human microplasmin in complex with textilinin-1, an aprotinin-like inhibitor from the Australian brown snake
    PLoS ONE (2013) 8, e54104-e54104. PubMed  Europe PubMed DOI  PMC  EPMC  S
  101. Saupe,S.M., Leubner,S., Betz,M., Klebe,G. and Steinmetzer,T.
    Development of new cyclic plasmin inhibitors with excellent potency and selectivity
    J Med Chem (2013) 56, 820-831. PubMed  Europe PubMed DOI  I
  102. Tse,L.V., Marcano,V.C., Huang,W., Pocwierz,M.S. and Whittaker,G.R.
    Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase
    J Virol (2013) 87, 5161-5169. PubMed  Europe PubMed DOI
    103. 2012
  103. Barthel,D., Schindler,S. and Zipfel,P.F.
    Plasminogen is a complement inhibitor
    J Biol Chem (2012) 287, 18831-18842. PubMed  Europe PubMed DOI
  104. Canas,O., Parra,A.Q. and Ramirez,L.F.A.
    Porcine plasmin: determination of kinetic parameters and comparison with human plasmin
    Iatreia (2012) 25, 111-119.
  105. Castellino,F.J.
    Plasmin
    [ISSN:978-0-12-407742-3] (2012) 3, 2958-2968. DOI
  106. Deryugina,E.I. and Quigley,J.P.
    Cell surface remodeling by plasmin: a new function for an old enzyme
    J Biomed Biotechnol (2012) 2012, 564259-564259. PubMed  Europe PubMed DOI  PMC  EPMC
  107. Gohda,K., Teno,N., Wanaka,K. and Tsuda,Y.
    Predicting subsite interactions of plasmin with substrates and inhibitors through computational docking analysis
    J Enzyme Inhib Med Chem (2012) 27, 571-577. PubMed  Europe PubMed DOI  P  I
  108. Haerteis,S., Krappitz,M., Diakov,A., Krappitz,A., Rauh,R. and Korbmacher,C.
    Plasmin and chymotrypsin have distinct preferences for channel activating cleavage sites in the gamma subunit of the human epithelial sodium channel
    J Gen Physiol (2012) 140, 375-389. PubMed  Europe PubMed DOI  P
  109. Kawao,N., Nagai,N., Tamura,Y., Horiuchi,Y., Okumoto,K., Okada,K., Suzuki,Y., Umemura,K., Yano,M., Ueshima,S., Kaji,H. and Matsuo,O.
    Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo
    Thromb Haemost (2012) 107, 749-759. PubMed  Europe PubMed DOI  K
  110. Koch,T.K., Reuter,M., Barthel,D., Bohm,S., van den Elsen,J., Kraiczy,P., Zipfel,P.F. and Skerka,C.
    Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b
    PLoS ONE (2012) 7, e47638-e47638. PubMed  Europe PubMed DOI  PMC  EPMC
  111. Law,R.H., Caradoc-Davies,T., Cowieson,N., Horvath,A.J., Quek,A.J., Encarnacao,J.A., Steer,D., Cowan,A., Zhang,Q., Lu,B.G., Pike,R.N., Smith,A.I., Coughlin,P.B. and Whisstock,J.C.
    The X-ray crystal structure of full-length human plasminogen
    Cell Rep (2012) 1, 185-190. PubMed  Europe PubMed DOI  S
  112. Saupe,S.M. and Steinmetzer,T.
    A new strategy for the development of highly potent and selective plasmin inhibitors
    J Med Chem (2012) 55, 1171-1180. PubMed  Europe PubMed DOI  I
  113. Singh,S., Ashish and Dikshit,K.L.
    Pro42 and Val45 of staphylokinase modulate intermolecular interactions of His43-Tyr44 pair and specificity of staphylokinase-plasmin activator complex
    FEBS Lett (2012) 586, 653-658. PubMed  Europe PubMed DOI
  114. Svenningsen,P., Skott,O. and Jensen,B.L.
    Proteinuric diseases with sodium retention: is plasmin the link?
    Clin Exp Pharmacol Physiol (2012) 39, 117-124. PubMed  Europe PubMed DOI
  115. Swedberg,J.E. and Harris,J.M.
    Natural and engineered plasmin inhibitors: applications and design strategies
    Chembiochem (2012) 13, 336-348. PubMed  Europe PubMed DOI  V  I
  116. Syrovets,T., Lunov,O. and Simmet,T.
    Plasmin as a proinflammatory cell activator
    J Leukoc Biol (2012) 92, 509-519. PubMed  Europe PubMed DOI  V
  117. Teno,N., Otsubo,T., Gohda,K., Wanaka,K., Sueda,T., Ikeda,K., Hijikata-Okunomiya,A. and Tsuda,Y.
    Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead
    J Pept Sci (2012) 18, 620-625. PubMed  Europe PubMed DOI  I
  118. Xue,Y., Bodin,C. and Olsson,K.
    Crystal structure of the native plasminogen reveals an activation-resistant compact conformation
    J Thromb Haemost (2012) 10, 1385-1396. PubMed  Europe PubMed DOI  S
    119. 2011
  119. Brauer,R., Beck,I.M., Roderfeld,M., Roeb,E. and Sedlacek,R.
    Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen
    BMC Biochem (2011) 12, 38-38. PubMed  Europe PubMed DOI
  120. Canas,B.O., Quijano,P.A. and Arbelaez,R.F.
    Activation and comparative kinetics of Ovis aries plasmin with human plasmin
    Rev MVZ Cordoba (2011) 16, 2364-2371.
  121. Dahiya,M., Singh,S., Rajamohan,G., Sethi,D., Ashish and Dikshit,K.L.
    Intermolecular interactions in staphylokinase-plasmin(ogen) bimolecular complex: function of His43 and Tyr44
    FEBS Lett (2011) 585, 1814-1820. PubMed  Europe PubMed DOI
  122. Laha,M., Panizzi,P., Nahrendorf,M. and Bock,P.E.
    Engineering streptokinase for generation of active site-labeled plasminogen analogs
    Anal Biochem (2011) 415, 105-115. PubMed  Europe PubMed DOI
  123. Marder,V.J.
    Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin
    J Thromb Haemost (2011) 9 Suppl 1, 364-373. PubMed  Europe PubMed DOI  U
  124. Moroy,G., Bourguet,E., Decarme,M., Sapi,J., Alix,A.J., Hornebeck,W. and Lorimier,S.
    Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s)
    Biochem Pharmacol (2011) 81, 626-635. PubMed  Europe PubMed DOI  I
  125. Schaller,J. and Gerber,S.S.
    The plasmin-antiplasmin system: structural and functional aspects
    Cell Mol Life Sci (2011) 68, 785-801. PubMed  Europe PubMed DOI  V
  126. Swedberg,J.E. and Harris,J.M.
    Plasmin substrate binding site cooperativity guides the design of potent peptide aldehyde inhibitors
    Biochemistry (2011) 50, 8454-8462. PubMed  Europe PubMed DOI  I
  127. Teno,N., Gohda,K., Wanaka,K., Sueda,T. and Tsuda,Y.
    Identification of novel plasmin inhibitors possessing nitrile moiety as warhead
    Bioorg Med Chem Lett (2011) 21, 6305-6309. PubMed  Europe PubMed DOI  I
  128. Venkatraman,L., Li,H., Dewey,C.F., Jr., White,J.K., Bhowmick,S.S., Yu,H. and Tucker-Kellogg,L.
    Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro
    Biophys J (2011) 101, 1825-1834. PubMed  Europe PubMed DOI  PMC  EPMC
  129. Wu,W.C., Chen,C.C., Liu,C.H., Wang,N.K., Chen,K.J., Chen,T.L., Hwang,Y.S., Li,L.M. and Lai,C.C.
    Plasmin treatment accelerates vascular endothelial growth factor clearance from rabbit eyes
    Invest Ophthalmol Vis Sci (2011) 52, 6162-6167. PubMed  Europe PubMed DOI  U
  130. Yamamoto,H., Ben,S., Saitoh,S., Kamata,K., Iguchi,K. and Hoshino,M.
    Plasmin: its role in the extracellular processing of progalanin in tumor tissue
    Protein Pept Lett (2011) 18, 1204-1211. PubMed  Europe PubMed DOI
    131. 2010
  131. Dejouvencel,T., Doeuvre,L., Lacroix,R., Plawinski,L., Dignat-George,F., Lijnen,H.R. and Angles-Cano,E.
    Fibrinolytic cross-talk: a new mechanism for plasmin formation
    Blood (2010) 115, 2048-2056. PubMed  Europe PubMed DOI
  132. Hoover-Plow,J.
    Does plasmin have anticoagulant activity?
    Vasc Health Risk Manag (2010) 6, 199-205. PubMed  Europe PubMed  PMC  EPMC
  133. Ismail,B. and Nielsen,S.S.
    Invited review: Plasmin protease in milk: current knowledge and relevance to dairy industry
    J Dairy Sci (2010) 93, 4999-5009. PubMed  Europe PubMed DOI
  134. Iwaki,T., Malinverno,C., Smith,D., Xu,Z., Liang,Z., Ploplis,V.A. and Castellino,F.J.
    The generation and characterization of mice expressing a plasmin-inactivating active site mutation
    J Thromb Haemost (2010) 8, 2341-2344. PubMed  Europe PubMed DOI  K
  135. Marder,V.J., Jahan,R., Gruber,T., Goyal,A. and Arora,V.
    Thrombolysis with plasmin: implications for stroke treatment
    Stroke (2010) 41, S45-S49. PubMed  Europe PubMed DOI  U
  136. Marder,V.J., Manyak,S., Gruber,T., Goyal,A., Moreno,G., Hunt,J., Bromirski,J., Scuderi,P., Petteway,S.R., Jr. and Novokhatny,V.
    Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2-5
    Thromb Haemost (2010) 104, 780-787. PubMed  Europe PubMed DOI  U
    137. 2009
  137. Aneja,R., Datt,M., Singh,B., Kumar,S. and Sahni,G.
    Identification of a new exosite involved in catalytic turnover by the streptokinase-plasmin activator complex during human plasminogen activation
    J Biol Chem (2009) 284, 32642-32650. PubMed  Europe PubMed DOI
  138. Hofmann,S.C., Voith,U., Schonau,V., Sorokin,L., Bruckner-Tuderman,L. and Franzke,C.W.
    Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97
    J Invest Dermatol (2009) 129, 1730-1739. PubMed  Europe PubMed DOI
  139. Nogami,K., Nishiya,K., Saenko,E.L., Takeyama,M., Ogiwara,K., Yoshioka,A. and Shima,M.
    Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36
    J Biol Chem (2009) 284, 6934-6945. PubMed  Europe PubMed DOI  PMC  EPMC  P
  140. Ohtsuka,K., Maekawa,I., Waki,M. and Takenaka,S.
    Electrochemical assay of plasmin activity and its kinetic analysis
    Anal Biochem (2009) 385, 293-299. PubMed  Europe PubMed DOI  A
  141. Purwin,M., Bruzgo,I., Markowska,A. and Midura-Nowaczek,K.
    Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors
    Pharmazie (2009) 64, 765-767. PubMed  Europe PubMed DOI  I
  142. Svenningsen,P., Uhrenholt,T.R., Palarasah,Y., Skjodt,K., Jensen,B.L. and Skott,O.
    Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations
    Am J Physiol Regul Integr Comp Physiol (2009) 297, R1733-R1741. PubMed  Europe PubMed DOI
  143. Yuan,H., Vance,K.M., Junge,C.E., Geballe,M.T., Snyder,J.P., Hepler,J.R., Yepes,M., Low,C.M. and Traynelis,S.F.
    The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors
    J Biol Chem (2009) 284, 12862-12873. PubMed  Europe PubMed DOI  PMC  EPMC  P
  144. Zhang,D., Jiang,S., Ma,J., Jiang,J., Pan,D. and Xu,X.
    Molecular cloning, characterization and expression analysis of a clip-domain serine protease from pearl oyster Pinctada fucata
    Fish Shellfish Immunol (2009) 26, 662-668. PubMed  Europe PubMed DOI
    145. 2008
  145. Gray,K. and Ellis,V.
    Activation of pro-BDNF by the pericellular serine protease plasmin
    FEBS Lett (2008) 582, 907-910. PubMed  Europe PubMed DOI  P
  146. Hunt,J.A., Petteway,S.R., Jr., Scuderi,P. and Novokhatny,V.
    Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin
    Thromb Haemost (2008) 100, 413-419. PubMed  Europe PubMed DOI  E
  147. Lei,H., Velez,G., Hovland,P., Hirose,T. and Kazlauskas,A.
    Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy
    Invest Ophthalmol Vis Sci (2008) 49, 42-48. PubMed  Europe PubMed DOI  T
  148. Marder,V.J.
    Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator
    Thromb Res (2008) 122 Suppl 3, S9-S9. PubMed  Europe PubMed DOI  U
  149. Passero,C.J., Mueller,G.M., Rondon-Berrios,H., Tofovic,S.P., Hughey,R.P. and Kleyman,T.R.
    Plasmin activates epithelial Na+ channels by cleaving the gamma subunit
    J Biol Chem (2008) 283, 36586-36591. PubMed  Europe PubMed DOI  PMC  EPMC
  150. Tanka-Salamon,A., Tenekedjiev,K., Machovich,R. and Kolev,K.
    Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids. Identification of kinetic parameters from continuous enzymatic assay with Monte Carlo simulation
    FEBS J (2008) 275, 1274-1282. PubMed  Europe PubMed DOI  PMC  EPMC  A  I
    151. 2007
  151. Devy,L., Rabbani,S.A., Stochl,M., Ruskowski,M., Mackie,I., Naa,L., Toews,M., van Gool,R., Chen,J., Ley,A., Ladner,R.C., Dransfield,D.T. and Henderikx,P.
    PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor
    Neoplasia (2007) 9, 927-937. PubMed  Europe PubMed DOI  PMC  EPMC
  152. Gladysheva,I.P., Sazonova,I.Y., Houng,A., Hedstrom,L. and Reed,G.L.
    Regulation of nonproteolytic active site formation in plasminogen
    Biochemistry (2007) 46, 8879-8887. PubMed  Europe PubMed DOI
  153. Grundy,J.E., Hancock,M.A., Meixner,S.C., MacKenzie,R.C., Koschinsky,M.L. and Pryzdial,E.L.
    Plasminogen binds to plasmin-modulated factor Xa by Ca (2+) - and C-terminal lysine-dependent and -independent interactions
    Thromb Haemost (2007) 97, 38-44. PubMed  Europe PubMed DOI
  154. Markowska,A., Midura-Nowaczek,K. and Bruzgo,I.
    Low molecular peptides as potential inhibitors of plasmin
    Acta Pol Pharm (2007) 64, 355-358. PubMed  Europe PubMed  I
  155. Nogami,K., Shima,M., Matsumoto,T., Nishiya,K., Tanaka,I. and Yoshioka,A.
    Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation
    J Biol Chem (2007) 282, 5287-5295. PubMed  Europe PubMed DOI  P
  156. [YEAR:14-2-2007]Sheehan,J.J., Zhou,C., Gravanis,I., Rogove,A.D., Wu,Y.P., Bogenhagen,D.F. and Tsirka,S.E.
    Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice
    J Neurosci (14-2-2007) 27, 1738-1745. PubMed  Europe PubMed DOI  K
  157. [YEAR:28-1-2007]Stillfried,G.E., Saunders,D.N. and Ranson,M.
    Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity
    Breast Cancer Res (28-1-2007) 9, R14-R14. PubMed  Europe PubMed DOI  PMC  EPMC
    158. 2006
  158. Rizzo,S., Pellegrini,G., Benocci,F., Belting,C., Baicchi,U. and Vispi,M.
    Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery
    Retina (2006) 26, 792-796. PubMed  Europe PubMed DOI  U
  159. [YEAR:11-9-2006]Xue,F. and Seto,C.T.
    Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity
    Bioorg Med Chem (11-9-2006) 14, 8467-8487. PubMed  Europe PubMed DOI  I
    160. 2005
  160. Castellino,F.J. and Ploplis,V.A.
    Structure and function of the plasminogen/plasmin system
    Thromb Haemost (2005) 93, 647-654. PubMed  Europe PubMed DOI  V
  161. Comer,M.B., Cackett,K.S., Gladwell,S., Wood,L.M. and Dawson,K.M.
    Thrombolytic activity of BB-10153, a thrombin-activatable plasminogen
    J Thromb Haemost (2005) 3, 146-153. PubMed  Europe PubMed DOI
  162. Ho-Tin-Noe,B., Rojas,G., Vranckx,R., Lijnen,H.R. and Angles-Cano,E.
    Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis
    FEBS J (2005) 272, 3387-3400. PubMed  Europe PubMed DOI
  163. Kwon,M., Yoon,C.S., Jeong,W., Rhee,S.G. and Waisman,D.M.
    Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin
    J Biol Chem (2005) 280, 23584-23592. PubMed  Europe PubMed DOI
  164. [YEAR:23-12-2005]Quagraine,M.O., Tan,F., Tamei,H., Erdos,E.G. and Skidgel,R.A.
    Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N
    Biochem J (23-12-2005) 388, 81-91. PubMed  Europe PubMed DOI  PMC  EPMC
  165. [YEAR:12-8-2005]Warejcka,D.J. and Twining,S.S.
    Specific conformational changes of plasminogen induced by chloride ions, 6-aminohexanoic acid and benzamidine, but not the overall openness of plasminogen regulate, production of biologically active angiostatins
    Biochem J (12-8-2005) 392, 703-712. PubMed  Europe PubMed DOI  PMC  EPMC  I
  166. [YEAR:14-10-2005]Xue,F. and Seto,C.T.
    A comparison of cyclohexanone and tetrahydro-4H-thiopyran-4-one 1,1-dioxide as pharmacophores for the design of peptide-based inhibitors of the serine protease plasmin
    J Org Chem (14-10-2005) 70, 8309-8321. PubMed  Europe PubMed DOI  I
  167. [YEAR:3-11-2005]Xue,F. and Seto,C.T.
    Selective inhibitors of the serine protease plasmin: probing the S3 and S3' subsites using a combinatorial library
    J Med Chem (3-11-2005) 48, 6908-6917. PubMed  Europe PubMed DOI  I
    168. 2004
  168. [YEAR:10-9-2004]Beaufort,N., Leduc,D., Rousselle,J.C., Namane,A., Chignard,M. and Pidard,D.
    Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells
    FEBS Lett (10-9-2004) 574, 89-94. PubMed  Europe PubMed DOI
  169. [YEAR:27-9-2004]Boxrud,P.D., Verhamme,I.M. and Bock,P.E.
    Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase
    J Biol Chem (27-9-2004) 279, 36633-36641. PubMed  Europe PubMed DOI
  170. Castellino,F.J.
    Plasmin
    [ISSN:0-12-079610-4] (2004) 2, 1692-1699.  V
  171. [YEAR:29-10-2004]Ehinger,S., Schubert,W.D., Bergmann,S., Hammerschmidt,S. and Heinz,D.W.
    Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites
    J Mol Biol (29-10-2004) 343, 997-1005. PubMed  Europe PubMed DOI
  172. Gandorfer,A., Rohleder,M., Sethi,C., Eckle,D., Welge-Lussen,U., Kampik,A., Luthert,P. and Charteris,D.
    Posterior vitreous detachment induced by microplasmin
    Invest Ophthalmol Vis Sci (2004) 45, 641-647. PubMed  Europe PubMed DOI
  173. Novokhatny,V.V., Jesmok,G.J., Landskroner,K.A., Marder,V.J. and Zimmerman,T.P.
    Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
    Trends Pharmacol Sci (2004) 25, 72-75. PubMed  Europe PubMed DOI  U
  174. Ohyama,S., Harada,T., Chikanishi,T., Miura,Y. and Hasumi,K.
    Nonlysine-analog plasminogen modulators promote autoproteolytic generation of plasmin(ogen) fragments with angiostatin-like activity
    Eur J Biochem (2004) 271, 809-820. PubMed  Europe PubMed DOI
  175. Samara,G.J., Schaffner,A.D., Eisenstat,J. and Nguyen,H.L.
    The effects of the plasminogen pathway on scar tissue formation
    Laryngoscope (2004) 114, 46-49. PubMed  Europe PubMed DOI  K
  176. [YEAR:27-8-2004]Sun,H., Ringdahl,U., Homeister,J.W., Fay,W.P., Engleberg,N.C., Yang,A.Y., Rozek,L.S., Wang,X., Sjobring,U. and Ginsburg,D.
    Plasminogen is a critical host pathogenicity factor for group A streptococcal infection
    Science (27-8-2004) 305, 1283-1286. PubMed  Europe PubMed DOI
  177. Syrovets,T. and Simmet,T.
    Novel aspects and new roles for the serine protease plasmin
    Cell Mol Life Sci (2004) 61, 873-885. PubMed  Europe PubMed DOI
  178. [YEAR:1-8-2004]Terzyan,S., Wakeham,N., Zhai,P., Rodgers,K. and Zhang,X.C.
    Characterization of Lys-698-to-Met substitution in human plasminogen catalytic domain
    Proteins (1-8-2004) 56, 277-284. PubMed  Europe PubMed DOI
  179. [YEAR:24-9-2004]Ward,P.N., Field,T.R., Rosey,E.L., Abu-Median,A.B., Lincoln,R.A. and Leigh,J.A.
    Complex interactions between bovine plasminogen and streptococcal plasminogen activator PauA
    J Mol Biol (24-9-2004) 342, 1101-1114. PubMed  Europe PubMed DOI
    180. 2003
  180. [YEAR:15-4-2003]Behrendt,N., List,K., Andreasen,P.A. and Dano,K.
    The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation
    Biochem J (15-4-2003) 371, 277-287. PubMed  Europe PubMed DOI  PMC  EPMC
  181. Guinn,L. and Doctor,V.M.
    Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride
    Eur J Drug Metab Pharmacokinet (2003) 28, 315-320. PubMed  Europe PubMed
  182. [YEAR:31-10-2003]Heinemann,F.S., Korza,G. and Ozols,J.
    A plasminogen-like protein selectively degrades stearoyl-CoA desaturase in liver microsomes
    J Biol Chem (31-10-2003) 278, 42966-42975. PubMed  Europe PubMed DOI
  183. Miles,L.A., Castellino,F.J. and Gong,Y.
    Critical role for conversion of Glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces
    Trends Cardiovasc Med (2003) 13, 21-30. PubMed  Europe PubMed DOI
  184. Nowak,P. and Zgirski,A.
    Effects of metal ions on activity of plasmin
    Biol Trace Elem Res (2003) 93, 87-94. PubMed  Europe PubMed DOI
  185. Rakic,J.M., Maillard,C., Jost,M., Bajou,K., Masson,V., Devy,L., Lambert,V., Foidart,J.M. and Noel,A.
    Role of plasminogen activator-plasmin system in tumor angiogenesis
    Cell Mol Life Sci (2003) 60, 463-473. PubMed  Europe PubMed DOI
  186. van der Laan,W.H., Ronday,H.K., TeKoppele,J.M., Breedveld,F.C., Huizinga,T.W. and Verheijen,J.H.
    No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study
    Clin Exp Rheumatol (2003) 21, 359-362. PubMed  Europe PubMed  I
    187. 2002
  187. [YEAR:22-2-2002]Abato,P., Yuen,C.M., Cubanski,J.Y. and Seto,C.T.
    Inhibitors of plasmin that extend into both the S and S' binding sites: Cooperative interactions between S1 and S2
    J Org Chem (22-2-2002) 67, 1184-1191. PubMed  Europe PubMed DOI  I
  188. [YEAR:6-9-2002]Burysek,L., Syrovets,T. and Simmet,T.
    The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and Janus kinase (JAK)/STAT signaling pathways
    J Biol Chem (6-9-2002) 277, 33509-33517. PubMed  Europe PubMed DOI
  189. Lapchak,P.A., Araujo,D.M., Pakola,S., Song,D., Wei,J. and Zivin,J.A.
    Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits
    Stroke (2002) 33, 2279-2284. PubMed  Europe PubMed DOI
  190. [YEAR:13-9-2002]Tarui,T., Majumdar,M., Miles,L.A., Ruf,W. and Takada,Y.
    Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin
    J Biol Chem (13-9-2002) 277, 33564-33570. PubMed  Europe PubMed DOI
    191. 2001
  191. [YEAR:13-7-2001]Boxrud,P.D., Verhamme,I.M., Fay,W.P. and Bock,P.E.
    Streptokinase triggers conformational activation of plasminogen through specific interactions of the amino-terminal sequence and stabilizes the active zymogen conformation
    J Biol Chem (13-7-2001) 276, 26084-26089. PubMed  Europe PubMed DOI
  192. [YEAR:1-6-2001]Gong,Y., Kim,S.O., Felez,J., Grella,D.K., Castellino,F.J. and Miles,L.A.
    Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface
    J Biol Chem (1-6-2001) 276, 19078-19083. PubMed  Europe PubMed DOI
  193. [YEAR:6-7-2001]Jiang,Q., Taupenot,L., Mahata,S.K., Mahata,M., O'Connor,D.T., Miles,L.A. and Parmer,R.J.
    Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release
    J Biol Chem (6-7-2001) 276, 25022-25029. PubMed  Europe PubMed DOI
  194. [YEAR:23-3-2001]Kassam,G., Kwon,M., Yoon,C.S., Graham,K.S., Young,M.K., Gluck,S. and Waisman,D.M.
    Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors
    J Biol Chem (23-3-2001) 276, 8924-8933. PubMed  Europe PubMed DOI
  195. [YEAR:27-3-2001]Kornblatt,J.A., Rajotte,I. and Heitz,F.
    Reaction of canine plasminogen with 6-aminohexanoate: A thermodynamic study combining fluorescence, circular dichroism, and isothermal titration calorimetry
    Biochemistry (27-3-2001) 40, 3639-3647. PubMed  Europe PubMed DOI
  196. Lee,A.Y.Y., Fredenburgh,J.C., Stewart,R.J., Rischke,J.A. and Weitz,J.I.
    Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin
    Thromb Haemost (2001) 85, 502-508. PubMed  Europe PubMed
  197. Marder,V.J., Landskroner,K., Novokhatny,V., Zimmerman,T.P., Kong,M., Kanouse,J.J. and Jesmok,G.
    Plasmin induces local thrombolysis without causing hemorrhage: A comparison with tissue plasminogen activator in the rabbit
    Thromb Haemost (2001) 86, 739-745. PubMed  Europe PubMed
  198. [YEAR:13-4-2001]Said,B., HaMai,D. and Matsumoto,D.C.
    Purification of follicular regulatory protein: Possible plasminogen identity
    Biochem Biophys Res Commun (13-4-2001) 282, 1045-1052. PubMed  Europe PubMed DOI
  199. Vakili,J., Standker,L., Detheux,M., Vassart,G., Forssmann,W.G. and Parmentier,M.
    Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active [9-74] processed variant
    J Immunol (2001) 167, 3406-3413. PubMed  Europe PubMed  P
    200. 2000
  200. Creemers,E., Cleutjens,J., Smits,J., Heymans,S., Moons,L., Collen,D., Daemen,M. and Carmeliet,P.
    Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction
    Am J Pathol (2000) 156, 1865-1873. PubMed  Europe PubMed DOI  PMC  EPMC  K
  201. [YEAR:5-7-2000]Harris,J.L., Backes,B.J., Leonetti,F., Mahrus,S., Ellman,J.A. and Craik,C.S.
    Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries
    Proc Natl Acad Sci U S A (5-7-2000) 97, 7754-7759. PubMed  Europe PubMed DOI  PMC  EPMC  P
  202. Okada,Y., Tsuda,Y., Tada,M., Wanaka,K., Okamoto,U., Hijikata-Okunomiya,A. and Okamoto,S.
    Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship
    Chem Pharm Bull (Tokyo) (2000) 48, 1964-1972. PubMed  Europe PubMed  I
  203. Parmer,R.J., Mahata,M., Gong,Y., Mahata,S.K., Jiang,Q., O'Connor,D.T., Xi,X.P. and Miles,L.A.
    Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion
    J Clin Invest (2000) 106, 907-915. PubMed  Europe PubMed DOI  PMC  EPMC
  204. Parry,M.A., Zhang,X.C. and Bode,I.
    Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues
    Trends Biochem Sci (2000) 25, 53-59. PubMed  Europe PubMed DOI
  205. Ploplis,V.A. and Castellino,F.J.
    Nonfibrinolytic functions of plasminogen
    Methods (2000) 21, 103-110. PubMed  Europe PubMed DOI
  206. [YEAR:1-2-2000]Samis,J.A., Ramsey,G.D., Walker,J.B., Nesheim,M.E. and Giles,A.R.
    Proteolytic processing of human coagulation factor IX by plasmin
    Blood (1-2-2000) 95, 943-951. PubMed  Europe PubMed
  207. van der Laan,W.H., Pap,T., Ronday,H.K., Grimbergen,J.M., Huisman,L.G., TeKoppele,J.M., Breedveld,F.C., Gay,R.E., Gay,S., Huizinga,T.W., Verheijen,J.H. and Quax,P.H.
    Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor
    Arthritis Rheum (2000) 43, 1710-1718. PubMed  Europe PubMed DOI
  208. Wang,S., Reed,G.L. and Hedstrom,L.
    Zymogen activation in the streptokinase-plasminogen complex. Ile1 is required for the formation of a functional active site
    Eur J Biochem (2000) 267, 3994-4001. PubMed  Europe PubMed DOI
  209. Wang,X., Terzyan,S., Tang,J., Loy,J.A., Lin,X. and Zhang,X.C.
    Human plasminogen catalytic domain undergoes an unusual conformational change upon activation
    J Mol Biol (2000) 295, 903-914. PubMed  Europe PubMed DOI  S
    210. 1999
  210. Nilsen,S.L. and Castellino,F.J.
    Expression of human plasminogen in Drosophila Schneider S2 cells
    Protein Expr Purif (1999) 16, 136-143. PubMed  Europe PubMed DOI  E
  211. [YEAR:24-8-1999]Peisach,E., Wang,J., de los Santos,T., Reich,E. and Ringe,D.
    Crystal structure of the proenzyme domain of plasminogen
    Biochemistry (24-8-1999) 38, 11180-11188. PubMed  Europe PubMed DOI  S
  212. Pryzdial,E.L., Lavigne,N., Dupuis,N. and Kessler,G.E.
    Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor
    J Biol Chem (1999) 274, 8500-8505. PubMed  Europe PubMed DOI
  213. [YEAR:19-11-1999]Santala,A., Saarinen,J., Kovanen,P. and Kuusela,P.
    Activation of interstitial collagenase, MMP-1, by Staphylococcus aureus cells having surface-bound plasmin: a novel role of plasminogen receptors of bacteria
    FEBS Lett (19-11-1999) 461, 153-156. PubMed  Europe PubMed DOI
    214. 1998
  214. [YEAR:15-7-1998]Farina,A.R., Tacconelli,A., Teti,A., Gulino,A. and Mackay,A.R.
    Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate
    Cancer Res (15-7-1998) 58, 2957-2960. PubMed  Europe PubMed
  215. [YEAR:5-5-1998]Jespers,L., Van Herzeele,N., Lijnen,H.R., Van Hoef,B., De Maeyer,M., Collen,D. and Lasters,I.
    Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex
    Biochemistry (5-5-1998) 37, 6380-6386. PubMed  Europe PubMed DOI
  216. Lijnen,H.R., Silence,J., Lemmens,G., Frederix,L. and Collen,D.
    Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system
    Thromb Haemost (1998) 79, 1171-1176. PubMed  Europe PubMed
  217. Ohkura,N., Hagihara,Y., Yoshimura,T., Goto,Y. and Kato,H.
    Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form
    Blood (1998) 91, 4173-4179. PubMed  Europe PubMed  P
  218. Parry,M.A., Fernandez-Catalan,C., Bergner,A., Huber,R., Hopfner,K.P., Schlott,B., Guhrs,K.H. and Bode,W.
    The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action
    Nat Struct Biol (1998) 5, 917-923. PubMed  Europe PubMed DOI  S
  219. [YEAR:3-4-1998]Takeda-Shitaka,M. and Umeyama,H.
    Elucidation of the cause for reduced activity of abnormal human plasmin containing an Ala55-Thr mutation: Importance of highly conserved Ala55 in serine proteases
    FEBS Lett (3-4-1998) 425, 448-452. PubMed  Europe PubMed DOI
  220. Wang,X., Lin,X., Loy,J.A., Tang,J. and Zhang,X.C.
    Crystal structure of the catalytic domain of human plasmin complexed with streptokinase
    Science (1998) 281, 1662-1665. PubMed  Europe PubMed DOI  S
    221. 1997
  221. Butenas,S., DiLorenzo,M.E. and Mann,K.G.
    Ultrasensitive fluorogenic substrates for serine proteases
    Thromb Haemost (1997) 78, 1193-1201. PubMed  Europe PubMed  A
  222. Okumura,Y., Sato,H., Seiki,M. and Kido,H.
    Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator
    FEBS Lett (1997) 402, 181-184. PubMed  Europe PubMed DOI
  223. Pirie-Shepherd,S.R., Stevens,R.D., Andon,N.L., Enghild,J.J. and Pizzo,S.V.
    Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2
    J Biol Chem (1997) 272, 7408-7411. PubMed  Europe PubMed DOI
  224. Schlott,B., Guhrs,K.H., Hartmann,M., Rocker,A. and Collen,D.
    Staphylokinase requires NH2-terminal proteolysis for plasminogen activation
    J Biol Chem (1997) 272, 6067-6072. PubMed  Europe PubMed DOI
  225. Wang,H., Prorok,M., Bretthauer,R.K. and Castellino,F.J.
    Serine-578 is a major phosphorylation locus in human plasma plasminogen
    Biochemistry (1997) 36, 8100-8106. PubMed  Europe PubMed DOI
    226. 1996
  226. Lijnen,H.R., Van Hoef,B. and Collen,D.
    Characterization of the murine plasminogen/urokinase-type plasminogen-activator system
    Eur J Biochem (1996) 241, 840-848. PubMed  Europe PubMed
  227. Romer,J., Bugge,T.H., Pyke,C., Lund,L.R., Flick,M.J., Degen,J.L. and Dano,K.
    Impaired wound healing in mice with a disrupted plasminogen gene
    Nat Med (1996) 2, 287-292. PubMed  Europe PubMed  K
  228. Ueshima,S., Okada,K. and Matsuo,O.
    Stabilization of plasmin by lysine derivatives
    Clin Chim Acta (1996) 245, 7-18. PubMed  Europe PubMed DOI  I
  229. Wijkmans,J.C.H.M., Nagel,A. and Bloemhoff,W.
    A novel chromogenic plasmin substrate Isoval-Phe-Lys-pNA-hydrochloride: a mild approach to the synthesis of N-alpha-peptidyl-L-lysine p-nitroanilides
    Int J Pept Res Ther (1996) 3, 107-112.  A
    230. 1995
  230. Bugge,T.H., Flick,M.J., Daugherty,C.C. and Degen,J.L.
    Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction
    Genes Dev (1995) 9, 794-807. PubMed  Europe PubMed  K
  231. Matsuzaki,T., Umeyama,H. and Kikumoto,R.
    Mechanisms of the selective inhibition of thrombin, factor Xa, plasmin and trypsin
    Pharmacochem Libr (1995) 23, 83-95. DOI  S  I
  232. [YEAR:1-11-1995]Ploplis,V.A., Carmeliet,P., Vazirzadeh,S., Van Vlaenderen,I., Moons,L., Plow,E.F. and Collen,D.
    Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice
    Circulation (1-11-1995) 92, 2585-2593. PubMed  Europe PubMed  K
  233. Plow,E.F., Herren,T., Redlitz,A., Miles,L.A. and Hoover-Plow,J.L.
    The cell biology of the plasminogen system
    FASEB J (1995) 9, 939-945. PubMed  Europe PubMed
  234. Redlitz,A., Tan,A.K., Eaton,D.L. and Plow,E.F.
    Plasma carboxypeptidases as regulators of the plasminogen system
    J Clin Invest (1995) 96, 2534-2538. PubMed  Europe PubMed DOI  PMC  EPMC
  235. Wang,J. and Reich,E.
    Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase
    Protein Sci (1995) 4, 1768-1779. PubMed  Europe PubMed DOI  PMC  EPMC
    236. 1994
  236. Donovan,F.M., Vaughan,P.J. and Cunningham,D.D.
    Regulation of protease nexin-1 target protease specificity by collagen type IV
    J Biol Chem (1994) 269, 17199-17205. PubMed  Europe PubMed
  237. Varadi,K., Philapitsch,A., Santa,T. and Schwarz,H.P.
    Activation and inactivation of human protein C by plasmin
    Thromb Haemost (1994) 71, 615-621. PubMed  Europe PubMed
    238. 1993
  238. [YEAR:15-7-1993]Azuma,H., Uno,Y., Shigekiyo,T. and Saito,S.
    Congenital plasminogen deficiency caused by a Ser572 to Pro mutation
    Blood (15-7-1993) 82, 475-480. PubMed  Europe PubMed  M
  239. [YEAR:15-4-1993]Collen,D., Schlott,B., Engelborghs,Y., Van Hoef,B., Hartmann,M., Lijnen,H.R. and Behnke,D.
    On the mechanism of the activation of human plasminogen by recombinant staphylokinase
    J Biol Chem (15-4-1993) 268, 8284-8289. PubMed  Europe PubMed  I
  240. Teno,N., Wanaka,K., Okada,Y., Taguchi,H., Okamoto,U., Hijikata-Okunomiya,A. and Okamoto,S.
    Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship
    Chem Pharm Bull (Tokyo) (1993) 41, 1079-1090. PubMed  Europe PubMed  I
    241. 1992
  241. Ichinose,A.
    Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis
    Biochemistry (1992) 31, 3113-3118. PubMed  Europe PubMed DOI
  242. Ponting,C.P., Marshall,J.M. and Cederholm-Williams,S.A.
    Plasminogen: a structural review
    Blood Coagul Fibrinolysis (1992) 3, 605-614. PubMed  Europe PubMed
    243. 1991
  243. Chain,D., Kreizman,T., Shapira,H. and Shaltiel,S.
    Plasmin cleavage of vitronectin. Identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1
    FEBS Lett (1991) 285, 251-256. PubMed  Europe PubMed DOI
    244. 1990
  244. Degen,S.J., Bell,S.M., Schaefer,L.A. and Elliott,R.W.
    Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17
    Genomics (1990) 8, 49-61. PubMed  Europe PubMed DOI
  245. [YEAR:15-4-1990]Petersen,T.E., Martzen,M.R., Ichinose,A. and Davie,E.W.
    Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system
    J Biol Chem (15-4-1990) 265, 6104-6111. PubMed  Europe PubMed  M
    246. 1989
  246. Whitefleet-Smith,J., Rosen,E., McLinden,J., Ploplis,V.A., Fraser,M.J., Tomlinson,J.E., McLean,J.W. and Castellino,F.J.
    Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system
    Arch Biochem Biophys (1989) 271, 390-399. PubMed  Europe PubMed  E
    247. 1988
  247. Castellino,F.J., Urano,T., de Serrano,V., Morris,J.P. and Chibber,B.A.
    Control of human plasminogen activation
    Haemostasis (1988) 18 Suppl 1, 15-23. PubMed  Europe PubMed
  248. [YEAR:15-9-1988]Hortin,G.L., Gibson,B.L. and Fok,K.F.
    Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin
    Biochem Biophys Res Commun (15-9-1988) 155, 591-596. PubMed  Europe PubMed
  249. Saino,T., Someno,T., Ishii,S., Aoyagi,T. and Umezawa,H.
    Protease-inhibitory activities of leupeptin analogues
    J Antibiot (Tokyo) (1988) 41, 220-225. PubMed  Europe PubMed  I
    250. 1987
  250. [YEAR:1-2-1987]Angliker,H., Wikstrom,P., Rauber,P. and Shaw,E.
    The synthesis of lysylfluoromethanes and their properties as inhibitors of trypsin, plasmin and cathepsin B
    Biochem J (1-2-1987) 241, 871-875. PubMed  Europe PubMed  PMC  EPMC  I
  251. Schaller,J., Marti,T., Rosselet,S.J., Kampfer,U. and Rickli,E.E.
    Amino acid sequence of the heavy chain of porcine plasmin. Comparison of the carbohydrate attachment sites with the human and bovine species
    Fibrinolysis (1987) 1, 91-102.
    252. 1986
  252. [YEAR:25-1-1986]Collen,D., Zamarron,C., Lijnen,H.R. and Hoylaerts,M.
    Activation of plasminogen by pro-urokinase. II. Kinetics
    J Biol Chem (25-1-1986) 261, 1259-1266. PubMed  Europe PubMed
  253. [YEAR:25-1-1986]Lijnen,H.R., Zamarron,C., Blaber,M., Winkler,M.E. and Collen,D.
    Activation of plasminogen by pro-urokinase. I. Mechanism
    J Biol Chem (25-1-1986) 261, 1253-1258. PubMed  Europe PubMed
    254. 1984
  254. Castellino,F.J.
    Biochemistry of human plasminogen
    Semin Thromb Hemost (1984) 10, 18-23. PubMed  Europe PubMed DOI
    255. 1982
  255. Friberger,P., Knos,M., Gustavsson,S., Aurell,L. and Claeson,G.
    12. A new specific substrate for the determination of plasmin activity
    Scand J Clin Lab Invest (1982) 42, 121-127. DOI  A
  256. Ranby,M.
    Studies on the kinetics of plasminogen activation by tissue plasminogen activator
    Biochim Biophys Acta (1982) 704, 461-469. PubMed  Europe PubMed
  257. Teger-Nilsson,A.-C., Friberger,P. and Gyzander,E.
    Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate
    Scand J Clin Lab Invest (1982) 42, 403-409. DOI  A
    258. 1981
  258. Castellino,F.J. and Powell,J.R.
    Human plasminogen
    Methods Enzymol (1981) 80, 365-378. PubMed  Europe PubMed DOI  V
  259. Robbins,K.C., Summaria,L. and Wohl,R.C.
    Human plasmin
    Methods Enzymol (1981) 80, 379-387. PubMed  Europe PubMed DOI  V
  260. [YEAR:1-9-1981]Suenson,E. and Thorsen,S.
    Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin
    Biochem J (1-9-1981) 197, 619-628. PubMed  Europe PubMed  PMC  EPMC
  261. [YEAR:29-5-1981]Thorsen,S., Clemmensen,I., Sottrup-Jensen,L. and Magnusson,S.
    Adsorption to fibrin of native fragments of known primary structure from human plasminogen
    Biochim Biophys Acta (29-5-1981) 668, 377-387. PubMed  Europe PubMed
    262. 1980
  262. Jackson,C.M. and Nemerson,Y.
    Blood coagulation
    Annu Rev Biochem (1980) 49, 765-811. PubMed  Europe PubMed DOI
  263. Kato,H., Adachi,N., Ohno,Y., Iwanaga,S., Takada,K. and Sakakibara,S.
    New fluorogenic peptide substrates for plasmin
    J Biochem (1980) 88, 183-190. PubMed  Europe PubMed  A
  264. [YEAR:10-11-1980]Lijnen,H.R., Hoylaerts,M. and Collen,D.
    Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein
    J Biol Chem (10-11-1980) 255, 10214-10222. PubMed  Europe PubMed
    265. 1979
  265. Castellino,F.J.
    A unique enzyme-protein substrate modifier reaction: plasmin/streptokinase interaction
    Trends Biochem Sci (1979) 4, 1-5.
  266. [YEAR:25-7-1979]Wiman,B., Lijnen,H.R. and Collen,D.
    On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen
    Biochim Biophys Acta (25-7-1979) 579, 142-154. PubMed  Europe PubMed
    267. 1978
  267. Goldsmith,G.H., Jr., Saito,H. and Ratnoff,O.S.
    The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments
    J Clin Invest (1978) 62, 54-60. PubMed  Europe PubMed DOI  PMC  EPMC
  268. [YEAR:10-3-1978]Sugino,H., Kakinuma,A. and Iwanaga,S.
    Plasminostreptin, a protein proteinase inhibitor produced by Streptomyces antifibrinolyticus. III. Elucidation of the primary structure
    J Biol Chem (10-3-1978) 253, 1546-1555. PubMed  Europe PubMed
  269. [YEAR:1-6-1978]Wiman,B., Boman,L. and Collen,D.
    On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
    Eur J Biochem (1-6-1978) 87, 143-146. PubMed  Europe PubMed
  270. [YEAR:15-3-1978]Wiman,B. and Collen,D.
    On the kinetics of the reaction between human antiplasmin and plasmin
    Eur J Biochem (15-3-1978) 84, 573-578. PubMed  Europe PubMed
    271. 1976
  271. Castellino,F.J. and Sodetz,J.M.
    Rabbit plasminogen and plasmin isozymes
    Methods Enzymol (1976) 45, 273-286. PubMed  Europe PubMed DOI  V
  272. Robbins,K.C. and Summaria,L.
    Plasminogen and plasmin
    Methods Enzymol (1976) 45, 257-273. PubMed  Europe PubMed DOI  V
    273. 1975
  273. Harpel,P.C. and Cooper,N.R.
    Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin
    J Clin Invest (1975) 55, 593-604. PubMed  Europe PubMed DOI  PMC  EPMC
  274. Robbins,K.C., Boreisha,I.G., Arzadon,L., Summaria,L. and Barlow,G.H.
    Physical and chemical properties of the NH2-terminal glutamic acid and lysine forms of human plasminogen and their derived plasmins with an NH2-terminal lysine heavy (A) chain. Comparative data
    J Biol Chem (1975) 250, 4044-4047. PubMed  Europe PubMed
  275. Wiman,B.W. and Wallen,P.
    Structural relationship between "glutamic acid" and "lysine" forms of human plasminogen and their interaction with the NH2- teminal activation peptide as studies by affinity chromatography
    Eur J Biochem (1975) 50, 489-494. PubMed  Europe PubMed
    276. 1973
  276. Coats,E.A.
    Comparative inhibition of thrombin, plasmin, trypsin, and complement by benzamidines using substituent constants and regression analysis
    J Med Chem (1973) 16, 1102-1106. PubMed  Europe PubMed  I
    277. 1972
  277. Wallen,P. and Wiman,B.
    Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen
    Biochim Biophys Acta (1972) 257, 122-134. PubMed  Europe PubMed
    278. 1970
  278. Wallen,P. and Wiman,B.
    Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations
    Biochim Biophys Acta (1970) 221, 20-30. PubMed  Europe PubMed
    279. 1969
  279. Chase,T., Jr. and Shaw,E.
    Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes
    Biochemistry (1969) 8, 2212-2224. PubMed  Europe PubMed DOI  I
  280. [YEAR:29-4-1969]Colman,R.W.
    Activation of plasminogen by human plasma kallikrein
    Biochem Biophys Res Commun (29-4-1969) 35, 273-279. PubMed  Europe PubMed
  281. Ratnoff,O.D., Pensky,J., Ogston,D. and Naff,G.B.
    The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor
    J Exp Med (1969) 129, 315-331. PubMed  Europe PubMed  PMC  EPMC
    282. 1967
  282. Robbins,K.C., Summaria,L., Hsieh,B. and Shah,R.J.
    The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin
    J Biol Chem (1967) 242, 2333-2342. PubMed  Europe PubMed
  283. Summaria,L., Hsieh,B., Groskopf,W.R. and Robbins,K.C.
    The isolation and characterization of the S-carboxymethyl beta (light) chain derivative of human plasmin. The localization of the active site on the beta (light) chain
    J Biol Chem (1967) 242, 5046-5052. PubMed  Europe PubMed
    284. 1965
  284. Hummel,B.C.W., Schor,J.M., Buck,F.F., Boggiano,E. and DeRenzo,E.C.
    Quantitative enzymic assay of human plasminogen and plasmin with azocasein as substrate
    Anal Biochem (1965) 11, 532-547.  A
    285. 1958
  285. [YEAR:1-11-1958]Norman,P.S. and Hill,B.M.
    Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma
    J Exp Med (1-11-1958) 108, 639-649. PubMed  Europe PubMed  PMC  EPMC
  286. [YEAR:1-7-1958]Norman,P.S.
    Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma
    J Exp Med (1-7-1958) 108, 53-68. PubMed  Europe PubMed  PMC  EPMC
    287. 1955
  287. Grossi,C.E. and Cliffton,E.E.
    The lysis of arterial thrombi in rabbits and dogs by use of activated human plasminogen (fibrinolysin) (plasmin)
    Surgery (1955) 37, 794-802. PubMed  Europe PubMed  U
    288. 1952
  288. Astrup,T. and Mullertz,S.
    The fibrin plate method for estimating fibrinolytic activity
    Arch Biochem Biophys (1952) 40, 346-351. PubMed  Europe PubMed  A
  289. Kocholaty,W., Ellis,W.W. and Jensen,H.
    Activation of plasminogen by trypsin and plasmin
    Blood (1952) 7, 882-890. PubMed  Europe PubMed
    290. 1947
  290. Astrup,T. and Permin,P.M.
    Fibrinolysis in the animal organism
    Nature (1947) 159, 681-682. PubMed  Europe PubMed
    291. 1945
  291. Christensen,L.R. and Macleod,C.M.
    A proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors
    J Gen Physiol (1945) 28, 559-583. PubMed  Europe PubMed  PMC  EPMC

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use